Caricamento...
Clinical development of nintedanib for advanced non-small-cell lung cancer
Angiogenesis is an essential process in the development, growth, and metastasis of malignant tumors including lung cancer. Several angiogenesis inhibitors have been developed as potential therapies for non-small-cell lung cancer (NSCLC). Nintedanib is a small-molecule tyrosine kinase inhibitor that...
Salvato in:
| Pubblicato in: | Ther Clin Risk Manag |
|---|---|
| Autori principali: | , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Dove Medical Press
2015
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4654540/ https://ncbi.nlm.nih.gov/pubmed/26622180 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/TCRM.S76646 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|